Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead (MSLV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01044472
Recruitment Status : Completed
First Posted : January 8, 2010
Last Update Posted : April 14, 2016
Information provided by (Responsible Party):
St. Jude Medical

Brief Summary:
The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

Condition or disease
Multi-site Left Ventricular Pacing

Detailed Description:
To evaluate the hemodynamic impact of different pacing MSLV configurations.

Study Type : Observational
Actual Enrollment : 61 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead
Study Start Date : February 2010
Actual Primary Completion Date : May 2010
Actual Study Completion Date : May 2010

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with standard CRT-D indications

Inclusion Criteria:

  • Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
  • Patients have signed an informed consent form indicating their willingness to participate to this study.

Exclusion Criteria:

  • Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
  • Patients with second or third degree AV Block
  • Patients with intrinsic atrial rhythm < 40 bpm
  • Patients with a previously implanted left ventricular pacing lead.
  • Patients who are pregnant.
  • Patients currently participating in a clinical investigation that includes an active treatment arm.
  • Patients under 18 years of age.
  • Patients with a life expectancy of less then 6 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01044472

Bad Krozingen, Germany
Kerckhoff - Klinik
Bad Nauheim, Germany
Herz-und Diabetes Zentrum NRW
Bad Oeynhausen, Germany
Bad Rothenfelde, Germany
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt, Germany
Städt. Klinikum
Ludwigshafen, Germany
Klinikum Rosenheim
Rosenheim, Germany
United Kingdom
Russells Hall
Dudley, United Kingdom
Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
St Thomas
London, United Kingdom
Sponsors and Collaborators
St. Jude Medical

Responsible Party: St. Jude Medical Identifier: NCT01044472     History of Changes
Other Study ID Numbers: CR-09-048-EU-HF
First Posted: January 8, 2010    Key Record Dates
Last Update Posted: April 14, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by St. Jude Medical: